Walkey Carl 4
4 · Neoleukin Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Walkey Carl
Senior Vice President
Transactions
- Award
Restricted Stock Units
2022-02-01+55,000→ 55,000 totalExercise: $0.00→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date.